Erythromycin (Eryc Delayed-Release, Pce) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Also sold as: Eryc Delayed-Release, Pce, Erybid, Ees-400
Some Erythromycin products are in shortage in Canada (1 of 16 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A macrolide antibiotic used to treat bacterial infections such as chest, skin and eye infections.
Products affected
1 / 16
In shortage since
Sep 29, 2017
Reports on file
42
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
ODAN-ERYTHROMYCIN
5MG · OINTMENT · ODAN LABORATORIES LTD
DIN 00641324 · since Jun 8, 2018, no end estimate · Demand increase for the drug.
Active shortage
ODAN-ERYTHROMYCIN
5MG · OINTMENT · ODAN LABORATORIES LTD
DIN 00641324 · since Sep 29, 2017, no end estimate · Disruption of the manufacture of the drug.
To be discontinued
PDP-ERYTHROMYCIN
5MG · OINTMENT · PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN 01912755
Resolved
PDP-ERYTHROMYCIN
5MG · OINTMENT · PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN 01912755 · ended Jul 8, 2026 · Shortage of an active ingredient.
Resolved
PDP-ERYTHROMYCIN
5MG · OINTMENT · PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN 01912755 · ended Apr 1, 2026 · Shortage of an active ingredient.
Discontinued
PDP-ERYTHROMYCIN
5MG · OINTMENT · PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN 01912755
Resolved
PDP-ERYTHROMYCIN
5MG · OINTMENT · PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN 01912755 · ended Oct 25, 2024 · Shortage of an inactive ingredient or component.
Resolved
ERYTHROMYCIN OPHTHALMIC OINTMENT USP
5MG · OINTMENT · STERI-MED PHARMA INC.
DIN 02326663 · ended Jul 12, 2023 · Demand increase for the drug.
DIN 00873454 · ended Apr 27, 2023 · Disruption of the manufacture of the drug.
Resolved
ERYTHROCIN I.V.
500MG · POWDER FOR SOLUTION · AMDIPHARM LIMITED
DIN 00682268 · ended Sep 26, 2022 · Delay in release. As of Sept 26 2022, release resolved.
Resolved
ERYTHROCIN I.V.
1G · POWDER FOR SOLUTION · AMDIPHARM LIMITED
DIN 00682276 · ended Sep 26, 2022 · Delay in release. Release resolved.
Showing 12 of 42 reports. All reports are on file with Health Canada.
What's happening
Erythromycin is currently affected by an active shortage report filed with Health Canada by ODAN LABORATORIES LTD.
The reported causes are: demand increase for the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Erythromycin is classified under “ANTIINFECTIVES” (ATC S01AA).
Recent changes
Jul 9, 2026
New report filed
Jul 9, 2026
Shortage resolved
Common questions
What is Erythromycin used for?
A macrolide antibiotic used to treat bacterial infections such as chest, skin and eye infections.
When will Erythromycin be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Erythromycin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class (antiinfectives)
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.